The subsidiary,
The group said it has "acquired about 80 percent" of its genomic data, and added that it now plans to "reinforce its R&D activities for artificial cultivation" of the mushroom.
Additional information was not provided.
The subsidiary,
The group said it has "acquired about 80 percent" of its genomic data, and added that it now plans to "reinforce its R&D activities for artificial cultivation" of the mushroom.
Additional information was not provided.